List of Tables
    Table 1. Antihyperuricemic Agents Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Antihyperuricemic Agents Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Inhibit Uric Acid Production Agents
    Table 4. Major Players of Promote Uric Acid Excretion Agents
    Table 5. Major Players of Others
    Table 6. Global Antihyperuricemic Agents Sales by Type (2017-2022) & (K Units)
    Table 7. Global Antihyperuricemic Agents Sales Market Share by Type (2017-2022)
    Table 8. Global Antihyperuricemic Agents Revenue by Type (2017-2022) & ($ million)
    Table 9. Global Antihyperuricemic Agents Revenue Market Share by Type (2017-2022)
    Table 10. Global Antihyperuricemic Agents Sale Price by Type (2017-2022) & (US$/Unit)
    Table 11. Global Antihyperuricemic Agents Sales by Distribution Channel (2017-2022) & (K Units)
    Table 12. Global Antihyperuricemic Agents Sales Market Share by Distribution Channel (2017-2022)
    Table 13. Global Antihyperuricemic Agents Revenue by Distribution Channel (2017-2022)
    Table 14. Global Antihyperuricemic Agents Revenue Market Share by Distribution Channel (2017-2022)
    Table 15. Global Antihyperuricemic Agents Sale Price by Distribution Channel (2017-2022) & (US$/Unit)
    Table 16. Global Antihyperuricemic Agents Sales by Company (2020-2022) & (K Units)
    Table 17. Global Antihyperuricemic Agents Sales Market Share by Company (2020-2022)
    Table 18. Global Antihyperuricemic Agents Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global Antihyperuricemic Agents Revenue Market Share by Company (2020-2022)
    Table 20. Global Antihyperuricemic Agents Sale Price by Company (2020-2022) & (US$/Unit)
    Table 21. Key Manufacturers Antihyperuricemic Agents Producing Area Distribution and Sales Area
    Table 22. Players Antihyperuricemic Agents Products Offered
    Table 23. Antihyperuricemic Agents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Antihyperuricemic Agents Sales by Geographic Region (2017-2022) & (K Units)
    Table 27. Global Antihyperuricemic Agents Sales Market Share Geographic Region (2017-2022)
    Table 28. Global Antihyperuricemic Agents Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global Antihyperuricemic Agents Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global Antihyperuricemic Agents Sales by Country/Region (2017-2022) & (K Units)
    Table 31. Global Antihyperuricemic Agents Sales Market Share by Country/Region (2017-2022)
    Table 32. Global Antihyperuricemic Agents Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global Antihyperuricemic Agents Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas Antihyperuricemic Agents Sales by Country (2017-2022) & (K Units)
    Table 35. Americas Antihyperuricemic Agents Sales Market Share by Country (2017-2022)
    Table 36. Americas Antihyperuricemic Agents Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas Antihyperuricemic Agents Revenue Market Share by Country (2017-2022)
    Table 38. Americas Antihyperuricemic Agents Sales by Type (2017-2022) & (K Units)
    Table 39. Americas Antihyperuricemic Agents Sales Market Share by Type (2017-2022)
    Table 40. Americas Antihyperuricemic Agents Sales by Distribution Channel (2017-2022) & (K Units)
    Table 41. Americas Antihyperuricemic Agents Sales Market Share by Distribution Channel (2017-2022)
    Table 42. APAC Antihyperuricemic Agents Sales by Region (2017-2022) & (K Units)
    Table 43. APAC Antihyperuricemic Agents Sales Market Share by Region (2017-2022)
    Table 44. APAC Antihyperuricemic Agents Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC Antihyperuricemic Agents Revenue Market Share by Region (2017-2022)
    Table 46. APAC Antihyperuricemic Agents Sales by Type (2017-2022) & (K Units)
    Table 47. APAC Antihyperuricemic Agents Sales Market Share by Type (2017-2022)
    Table 48. APAC Antihyperuricemic Agents Sales by Distribution Channel (2017-2022) & (K Units)
    Table 49. APAC Antihyperuricemic Agents Sales Market Share by Distribution Channel (2017-2022)
    Table 50. Europe Antihyperuricemic Agents Sales by Country (2017-2022) & (K Units)
    Table 51. Europe Antihyperuricemic Agents Sales Market Share by Country (2017-2022)
    Table 52. Europe Antihyperuricemic Agents Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe Antihyperuricemic Agents Revenue Market Share by Country (2017-2022)
    Table 54. Europe Antihyperuricemic Agents Sales by Type (2017-2022) & (K Units)
    Table 55. Europe Antihyperuricemic Agents Sales Market Share by Type (2017-2022)
    Table 56. Europe Antihyperuricemic Agents Sales by Distribution Channel (2017-2022) & (K Units)
    Table 57. Europe Antihyperuricemic Agents Sales Market Share by Distribution Channel (2017-2022)
    Table 58. Middle East & Africa Antihyperuricemic Agents Sales by Country (2017-2022) & (K Units)
    Table 59. Middle East & Africa Antihyperuricemic Agents Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa Antihyperuricemic Agents Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa Antihyperuricemic Agents Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Antihyperuricemic Agents Sales by Type (2017-2022) & (K Units)
    Table 63. Middle East & Africa Antihyperuricemic Agents Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa Antihyperuricemic Agents Sales by Distribution Channel (2017-2022) & (K Units)
    Table 65. Middle East & Africa Antihyperuricemic Agents Sales Market Share by Distribution Channel (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of Antihyperuricemic Agents
    Table 67. Key Market Challenges & Risks of Antihyperuricemic Agents
    Table 68. Key Industry Trends of Antihyperuricemic Agents
    Table 69. Antihyperuricemic Agents Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Antihyperuricemic Agents Distributors List
    Table 72. Antihyperuricemic Agents Customer List
    Table 73. Global Antihyperuricemic Agents Sales Forecast by Region (2023-2028) & (K Units)
    Table 74. Global Antihyperuricemic Agents Sales Market Forecast by Region
    Table 75. Global Antihyperuricemic Agents Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global Antihyperuricemic Agents Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas Antihyperuricemic Agents Sales Forecast by Country (2023-2028) & (K Units)
    Table 78. Americas Antihyperuricemic Agents Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC Antihyperuricemic Agents Sales Forecast by Region (2023-2028) & (K Units)
    Table 80. APAC Antihyperuricemic Agents Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe Antihyperuricemic Agents Sales Forecast by Country (2023-2028) & (K Units)
    Table 82. Europe Antihyperuricemic Agents Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa Antihyperuricemic Agents Sales Forecast by Country (2023-2028) & (K Units)
    Table 84. Middle East & Africa Antihyperuricemic Agents Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global Antihyperuricemic Agents Sales Forecast by Type (2023-2028) & (K Units)
    Table 86. Global Antihyperuricemic Agents Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global Antihyperuricemic Agents Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global Antihyperuricemic Agents Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global Antihyperuricemic Agents Sales Forecast by Distribution Channel (2023-2028) & (K Units)
    Table 90. Global Antihyperuricemic Agents Sales Market Share Forecast by Distribution Channel (2023-2028)
    Table 91. Global Antihyperuricemic Agents Revenue Forecast by Distribution Channel (2023-2028) & ($ Millions)
    Table 92. Global Antihyperuricemic Agents Revenue Market Share Forecast by Distribution Channel (2023-2028)
    Table 93. Takeda Pharmaceuticals Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 94. Takeda Pharmaceuticals Antihyperuricemic Agents Product Offered
    Table 95. Takeda Pharmaceuticals Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 96. Takeda Pharmaceuticals Main Business
    Table 97. Takeda Pharmaceuticals Latest Developments
    Table 98. Hikma Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 99. Hikma Antihyperuricemic Agents Product Offered
    Table 100. Hikma Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 101. Hikma Main Business
    Table 102. Hikma Latest Developments
    Table 103. Wockhardt Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 104. Wockhardt Antihyperuricemic Agents Product Offered
    Table 105. Wockhardt Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 106. Wockhardt Main Business
    Table 107. Wockhardt Latest Developments
    Table 108. West Ward Pharmaceuticals Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 109. West Ward Pharmaceuticals Antihyperuricemic Agents Product Offered
    Table 110. West Ward Pharmaceuticals Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 111. West Ward Pharmaceuticals Main Business
    Table 112. West Ward Pharmaceuticals Latest Developments
    Table 113. Rhea Pharmaceutical Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 114. Rhea Pharmaceutical Antihyperuricemic Agents Product Offered
    Table 115. Rhea Pharmaceutical Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 116. Rhea Pharmaceutical Main Business
    Table 117. Rhea Pharmaceutical Latest Developments
    Table 118. Medinova Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 119. Medinova Antihyperuricemic Agents Product Offered
    Table 120. Medinova Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 121. Medinova Main Business
    Table 122. Medinova Latest Developments
    Table 123. Odan Laboratories Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 124. Odan Laboratories Antihyperuricemic Agents Product Offered
    Table 125. Odan Laboratories Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 126. Odan Laboratories Main Business
    Table 127. Odan Laboratories Latest Developments
    Table 128. TEIJIN Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 129. TEIJIN Antihyperuricemic Agents Product Offered
    Table 130. TEIJIN Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 131. TEIJIN Main Business
    Table 132. TEIJIN Latest Developments
    Table 133. Casper Pharma Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 134. Casper Pharma Antihyperuricemic Agents Product Offered
    Table 135. Casper Pharma Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 136. Casper Pharma Main Business
    Table 137. Casper Pharma Latest Developments
    Table 138. Dr. Reddys Laboratories Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 139. Dr. Reddys Laboratories Antihyperuricemic Agents Product Offered
    Table 140. Dr. Reddys Laboratories Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 141. Dr. Reddys Laboratories Main Business
    Table 142. Dr. Reddys Laboratories Latest Developments
    Table 143. Teva Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 144. Teva Antihyperuricemic Agents Product Offered
    Table 145. Teva Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 146. Teva Main Business
    Table 147. Teva Latest Developments
    Table 148. Zydus Pharmaceuticals Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 149. Zydus Pharmaceuticals Antihyperuricemic Agents Product Offered
    Table 150. Zydus Pharmaceuticals Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 151. Zydus Pharmaceuticals Main Business
    Table 152. Zydus Pharmaceuticals Latest Developments
    Table 153. Mylan Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 154. Mylan Antihyperuricemic Agents Product Offered
    Table 155. Mylan Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 156. Mylan Main Business
    Table 157. Mylan Latest Developments
    Table 158. Sun Pharmaceutical Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 159. Sun Pharmaceutical Antihyperuricemic Agents Product Offered
    Table 160. Sun Pharmaceutical Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 161. Sun Pharmaceutical Main Business
    Table 162. Sun Pharmaceutical Latest Developments
    Table 163. APOTEX Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 164. APOTEX Antihyperuricemic Agents Product Offered
    Table 165. APOTEX Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 166. APOTEX Main Business
    Table 167. APOTEX Latest Developments
    Table 168. NorthStar Healthcare Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 169. NorthStar Healthcare Antihyperuricemic Agents Product Offered
    Table 170. NorthStar Healthcare Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 171. NorthStar Healthcare Main Business
    Table 172. NorthStar Healthcare Latest Developments
    Table 173. Ipca Laboratories Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 174. Ipca Laboratories Antihyperuricemic Agents Product Offered
    Table 175. Ipca Laboratories Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 176. Ipca Laboratories Main Business
    Table 177. Ipca Laboratories Latest Developments
    Table 178. Accord Healthcare Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 179. Accord Healthcare Antihyperuricemic Agents Product Offered
    Table 180. Accord Healthcare Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 181. Accord Healthcare Main Business
    Table 182. Accord Healthcare Latest Developments
    Table 183. Gentec Pharmaceutical Group Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 184. Gentec Pharmaceutical Group Antihyperuricemic Agents Product Offered
    Table 185. Gentec Pharmaceutical Group Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 186. Gentec Pharmaceutical Group Main Business
    Table 187. Gentec Pharmaceutical Group Latest Developments
    Table 188. Indoco Remedies Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 189. Indoco Remedies Antihyperuricemic Agents Product Offered
    Table 190. Indoco Remedies Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 191. Indoco Remedies Main Business
    Table 192. Indoco Remedies Latest Developments
    Table 193. Lupin Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 194. Lupin Antihyperuricemic Agents Product Offered
    Table 195. Lupin Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 196. Lupin Main Business
    Table 197. Lupin Latest Developments
    Table 198. Waterstone Pharmaceuticals Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 199. Waterstone Pharmaceuticals Antihyperuricemic Agents Product Offered
    Table 200. Waterstone Pharmaceuticals Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 201. Waterstone Pharmaceuticals Main Business
    Table 202. Waterstone Pharmaceuticals Latest Developments
    Table 203. ALP Pharm Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 204. ALP Pharm Antihyperuricemic Agents Product Offered
    Table 205. ALP Pharm Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 206. ALP Pharm Main Business
    Table 207. ALP Pharm Latest Developments
    Table 208. Jiangsu Hengrui Medicine Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 209. Jiangsu Hengrui Medicine Antihyperuricemic Agents Product Offered
    Table 210. Jiangsu Hengrui Medicine Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 211. Jiangsu Hengrui Medicine Main Business
    Table 212. Jiangsu Hengrui Medicine Latest Developments
    Table 213. Jiangsu Wanbang Biopharmaceuticals Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 214. Jiangsu Wanbang Biopharmaceuticals Antihyperuricemic Agents Product Offered
    Table 215. Jiangsu Wanbang Biopharmaceuticals Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 216. Jiangsu Wanbang Biopharmaceuticals Main Business
    Table 217. Jiangsu Wanbang Biopharmaceuticals Latest Developments
    Table 218. Hangzhou Zhuyangxin Pharmaceutical Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 219. Hangzhou Zhuyangxin Pharmaceutical Antihyperuricemic Agents Product Offered
    Table 220. Hangzhou Zhuyangxin Pharmaceutical Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 221. Hangzhou Zhuyangxin Pharmaceutical Main Business
    Table 222. Hangzhou Zhuyangxin Pharmaceutical Latest Developments
    Table 223. YiChang HEC ChangJiang Pharmaceutical Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 224. YiChang HEC ChangJiang Pharmaceutical Antihyperuricemic Agents Product Offered
    Table 225. YiChang HEC ChangJiang Pharmaceutical Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 226. YiChang HEC ChangJiang Pharmaceutical Main Business
    Table 227. YiChang HEC ChangJiang Pharmaceutical Latest Developments
    Table 228. KPC Pharmaceuticals Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 229. KPC Pharmaceuticals Antihyperuricemic Agents Product Offered
    Table 230. KPC Pharmaceuticals Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 231. KPC Pharmaceuticals Main Business
    Table 232. KPC Pharmaceuticals Latest Developments
    Table 233. Tonghua Limin Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 234. Tonghua Limin Antihyperuricemic Agents Product Offered
    Table 235. Tonghua Limin Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 236. Tonghua Limin Main Business
    Table 237. Tonghua Limin Latest Developments
    Table 238. Beijing Jialin Pharmaceutical Basic Information, Antihyperuricemic Agents Manufacturing Base, Sales Area and Its Competitors
    Table 239. Beijing Jialin Pharmaceutical Antihyperuricemic Agents Product Offered
    Table 240. Beijing Jialin Pharmaceutical Antihyperuricemic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 241. Beijing Jialin Pharmaceutical Main Business
    Table 242. Beijing Jialin Pharmaceutical Latest Developments
List of Figures
    Figure 1. Picture of Antihyperuricemic Agents
    Figure 2. Antihyperuricemic Agents Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Antihyperuricemic Agents Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Antihyperuricemic Agents Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Antihyperuricemic Agents Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Inhibit Uric Acid Production Agents
    Figure 10. Product Picture of Promote Uric Acid Excretion Agents
    Figure 11. Product Picture of Others
    Figure 12. Global Antihyperuricemic Agents Sales Market Share by Type in 2021
    Figure 13. Global Antihyperuricemic Agents Revenue Market Share by Type (2017-2022)
    Figure 14. Antihyperuricemic Agents Consumed in Hospital Pharmacies
    Figure 15. Global Antihyperuricemic Agents Market: Hospital Pharmacies (2017-2022) & (K Units)
    Figure 16. Antihyperuricemic Agents Consumed in Retail Pharmacies
    Figure 17. Global Antihyperuricemic Agents Market: Retail Pharmacies (2017-2022) & (K Units)
    Figure 18. Antihyperuricemic Agents Consumed in Online Pharmacies
    Figure 19. Global Antihyperuricemic Agents Market: Online Pharmacies (2017-2022) & (K Units)
    Figure 20. Global Antihyperuricemic Agents Sales Market Share by Distribution Channel (2017-2022)
    Figure 21. Global Antihyperuricemic Agents Revenue Market Share by Distribution Channel in 2021
    Figure 22. Antihyperuricemic Agents Revenue Market by Company in 2021 ($ Million)
    Figure 23. Global Antihyperuricemic Agents Revenue Market Share by Company in 2021
    Figure 24. Global Antihyperuricemic Agents Sales Market Share by Geographic Region (2017-2022)
    Figure 25. Global Antihyperuricemic Agents Revenue Market Share by Geographic Region in 2021
    Figure 26. Global Antihyperuricemic Agents Sales Market Share by Region (2017-2022)
    Figure 27. Global Antihyperuricemic Agents Revenue Market Share by Country/Region in 2021
    Figure 28. Americas Antihyperuricemic Agents Sales 2017-2022 (K Units)
    Figure 29. Americas Antihyperuricemic Agents Revenue 2017-2022 ($ Millions)
    Figure 30. APAC Antihyperuricemic Agents Sales 2017-2022 (K Units)
    Figure 31. APAC Antihyperuricemic Agents Revenue 2017-2022 ($ Millions)
    Figure 32. Europe Antihyperuricemic Agents Sales 2017-2022 (K Units)
    Figure 33. Europe Antihyperuricemic Agents Revenue 2017-2022 ($ Millions)
    Figure 34. Middle East & Africa Antihyperuricemic Agents Sales 2017-2022 (K Units)
    Figure 35. Middle East & Africa Antihyperuricemic Agents Revenue 2017-2022 ($ Millions)
    Figure 36. Americas Antihyperuricemic Agents Sales Market Share by Country in 2021
    Figure 37. Americas Antihyperuricemic Agents Revenue Market Share by Country in 2021
    Figure 38. United States Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Canada Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Mexico Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Brazil Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 42. APAC Antihyperuricemic Agents Sales Market Share by Region in 2021
    Figure 43. APAC Antihyperuricemic Agents Revenue Market Share by Regions in 2021
    Figure 44. China Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Japan Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 46. South Korea Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Southeast Asia Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 48. India Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Australia Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Europe Antihyperuricemic Agents Sales Market Share by Country in 2021
    Figure 51. Europe Antihyperuricemic Agents Revenue Market Share by Country in 2021
    Figure 52. Germany Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 53. France Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 54. UK Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Italy Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Russia Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Middle East & Africa Antihyperuricemic Agents Sales Market Share by Country in 2021
    Figure 58. Middle East & Africa Antihyperuricemic Agents Revenue Market Share by Country in 2021
    Figure 59. Egypt Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 60. South Africa Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Israel Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Turkey Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 63. GCC Country Antihyperuricemic Agents Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Manufacturing Cost Structure Analysis of Antihyperuricemic Agents in 2021
    Figure 65. Manufacturing Process Analysis of Antihyperuricemic Agents
    Figure 66. Industry Chain Structure of Antihyperuricemic Agents
    Figure 67. Channels of Distribution
    Figure 68. Distributors Profiles